The biotech industry is fueled by an increasing number of orphan drug formulations and increasing investment in advanced technologies. Given the industry’s steady growth prospects, investors could consider quality biotech stocks Regeneron Pharmaceuticals, Inc. (REGN), Corcept Therapeutics Incorporated (CORT), and Incyte Corporation (INCY).
The growing foothold of personalized medicine and an increasing number of orphan drug formulations are opening new avenues for biotechnology applications and are driving the influx of emerging and innovative biotechnology companies, further boosting the market revenue. The global biotechnology market is expected to grow at a CAGR of 14% until 2030.
